{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-068333","form_type":"8-K","ticker":"ATOS","cik":"0001488039","company_name":"ATOSSA THERAPEUTICS, INC.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.430295+00:00","generated_at":"2026-05-21T23:28:07.420109+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Atossa stockholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting","bullets":["Class I directors Steven C. Quay (28.4M for, 4.2M withheld) and Jonathan F. Finn (30.2M for, 2.4M withheld) elected.","Ratification of Ernst & Young as auditor passed with 55.8M for, 6.7M against, 1.4M abstain.","Non-binding advisory vote on executive compensation approved with 25.6M for, 6.5M against, 0.5M abstain.","Stockholders selected one-year frequency for future say-on-pay votes (29.3M votes for 1 year).","Record date March 20, 2025; 129,170,004 shares entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-068333","json":"https://secwatch.observer/filing/0000950170-25-068333.json","markdown":"https://secwatch.observer/filing/0000950170-25-068333.md","text":"https://secwatch.observer/filing/0000950170-25-068333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025068333/0000950170-25-068333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025068333/atos-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T23:28:07.420109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}